TABLE 1.
Patient baseline demographics.
| Total (N = 16) | |
|---|---|
| Age | |
| N | 16 |
| Mean (SD) | 52.4 (19.9) |
| Median | 45.5 |
| Q1, Q3 | 36.0, 75.0 |
| Sex | |
| Female | 7 (43.8%) |
| Male | 9 (56.3%) |
| Race | |
| American Indian or Alaska Native | 1 (6.3%) |
| Asian | 2 (12.5%) |
| White | 11 (68.8%) |
| Unknown | 2 (12.6%) |
| Ethnicity | |
| Hispanic or Latino | 4 (25.0%) |
| Not Hispanic or Latino | 11 (68.8%) |
| Unknown | 1 (6.3%) |
| PS | |
| 1 | 11 (68.8%) |
| 2 | 5 (31.3%) |
| ALL lineage | |
| B‐cell | 9 (31%) |
| T‐cell | 4 (25%) |
| Unknown | 3 (44%) |
| Prior treatment | |
| Bone marrow transplantation | 5 (31.3%) |
| Chemotherapy, NOS | 3 (18.8%) |
| Chemotherapy, multiple agents systemic | 11 (68.8%) |
| Immunotherapy | 4 (25.0%) |
| Limited radiation therapy | 1 (6.3%) |
| Prior therapy (NOS) | 3 (18.8%) |
| Radiation therapy (NOS) | 1 (6.3%) |
| Single agent systemic chemotherapy | 12 (75.0%) |
| Surgery | 15 (93.8%) |